- Home
- GOVX vs IVDA Comparison
GOVX vs IVDA Comparison
Compare GOVX & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | IVDA |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 3.2M |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GOVX | IVDA |
|---|---|---|
| Price | $0.59 | $0.27 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 584.9K | ★ 8.0M |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.38 |
| EPS | N/A | ★ N/A |
| Revenue | $2,489,145.00 | ★ $4,468,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 132.98 |
| 52 Week Low | $0.12 | $0.21 |
| 52 Week High | $4.40 | $2.24 |
Technical Indicators
Market Signals| Indicator | GOVX | IVDA |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 43.01 |
| Support Level | $0.14 | $0.24 |
| Resistance Level | $0.85 | $0.34 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 7.63 | 2.72 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.